Old Web
English
Sign In
Acemap
>
Paper
>
Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients
Treatment of Sézary Syndrome by anti-CD52 monoclonal antibodt Alemtuzumab: clinical and immunological findings in 24 patients
2010
Maria Grazia Bernengo
Pietro Quaglino
Federica Marenco
Mauro Novelli
Alessandra Comessatti
Paola Savoia
Maria Teresa Fierro
Keywords:
Immunology
CD52
Monoclonal
Alemtuzumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]